Toggle navigation
HOME
PORTFOLIO
NEWS
TEAM
CONTACT
Oklahoma City
Madeleine Cunningham
Craig Shimasaki
moleculera.com
Brian Clevinger
Moleculera Labs Awarded $500,000 Grant Funding to Develop Predictive Treatment Algorithm
January 11, 2024
BioSymetrics and Moleculera Partner to Advance Personalized Treatment for Immune-mediated Neuropsychiatric Disorders
October 1, 2024
on Moleculera
Moleculera Labs announces rebrand to Moleculera Biosciences as company expands into new sectors
July 30, 2024
on Moleculera
Moleculera Forms Collaboration with Quest Diagnostics to Broaden Access to its Neuropsychiatric Autoantibody Testing
January 17, 2024
on Moleculera
Moleculera and General Genomics to Provide Personalized Medicine for Neuropsychiatric Disorders
July 26, 2022
on Moleculera